8-KEarnings & ResultsRegulation FD

STRYKER CORP 8-K Report, Financial Results (Apr 20, 2011)

Filed April 20, 2011For Securities:SYK

Summary

This 8-K filing by Stryker Corporation (SYK), dated April 20, 2011, primarily serves to provide investors with updated financial reporting information. The company announced a change in its reporting structure, segregating operations into three distinct segments: Reconstructive, MedSurg, and Neurotechnology and Spine, effective from 2011. This change necessitated restating historical sales data to align with the new segment presentation, offering investors a more consistent view of performance across these key areas. The filing also includes supplemental sales information, specifically the dollar value of product sales for certain product lines, provided for the first time in a press release on April 19, 2011. This 8-K further furnishes historical dollar values for these product lines to enable comparative analysis for investors. While this information is provided to enhance transparency, it is furnished and not deemed "filed" under Section 18 of the Exchange Act, meaning it does not carry the same legal implications as formally filed financial statements.

Key Highlights

  • 1Stryker Corporation has reorganized its operations into three reportable business segments: Reconstructive, MedSurg, and Neurotechnology and Spine, effective 2011.
  • 2Historical sales data has been restated to conform to the new three-segment reporting structure.
  • 3The company is providing supplemental sales information, including the dollar value of product sales for certain product lines.
  • 4This supplemental information includes historical data for comparative purposes.
  • 5The purpose of this disclosure is to provide investors with enhanced transparency and comparative data.
  • 6The information furnished is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.

Frequently Asked Questions

The main purpose of this 8-K filing is to inform investors about Stryker's new business segment reporting structure and to provide supplemental sales data, including historical product line sales figures for better comparative analysis.

Effective in 2011, Stryker has segregated its operations into three reportable business segments: Reconstructive, MedSurg, and Neurotechnology and Spine.

Historical sales data is being restated to align with the new three-segment reporting structure, allowing for a consistent and comparable view of performance across these segments over time.

The information furnished in this 8-K is generally not considered 'filed' and thus not automatically incorporated into future filings. However, the company may expressly incorporate it by reference in specific future filings if it deems appropriate.